Status:
COMPLETED
Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression
Lead Sponsor:
University of Gaziantep
Conditions:
Migraine
Eligibility:
All Genders
Phase:
NA
Brief Summary
Migraine is a common and possible hereditary disease. Copy number variation (CNV) is a phenomenon in which parts of the genome are repeated and the number of repeats in the genome varies between indiv...
Detailed Description
Migraine is a common neurological disorder. Although they have different genetic bases according to their types, cholinergic receptors after calcium channels play an important role in the clinic and g...
Eligibility Criteria
Inclusion
- Migraine
Exclusion
- Vascular problems
Key Trial Info
Start Date :
April 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 2 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04912752
Start Date
April 5 2020
End Date
January 2 2021
Last Update
June 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicine
Gaziantep, Şehitkamil, Turkey (Türkiye), 27310